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A 14-year-old male had unilateral visual loss, blood-stained rhinorrhea, and generalized bruises with
fever. Ocular echography of the right eye revealed unilateral hemorrhagic retinal detachment with in-
ternal echogenicity, and therefore, a hemorrhagic retinal detachment (oculus dexter). Peripheral blood
smear tests revealed pancytopenia with 78% leukemic cells. Bone marrow sampling and genetic analysis
established the diagnosis of acute promyelocytic leukemia. Hemorrhagic retinal detachment can be
a presentation of acute promyelocytic leukemia, and thrombocytopenia and disseminated intravascular
coagulation may be the etiologies. The combined bleeding diathesis is a challenging status for surgical
management with poor visual prognosis.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Leukemias are a group of hematologic malignancies that involve
multiple organ systems. Ocular involvement is not uncommon in
acute leukemia, having been reported to occur in up to 90% of pa-
tients.1 The retina is more commonly involved in leukemia than
other ocular tissues.2 Reddy and Jackson reported that 49% of pa-
tients with acute lymphoblastic leukemia had retinopathy at
diagnosis.3 Typical retinal involvement of leukemia are round or
ﬂame-shaped hemorrhages with white component, intraretinal
hemorrhages, and cotton wool spots, comprising what is called
leukemic retinopathy.1 Although exudative retinal detachment has
only been reported in several cases of myeloproliferative and
lymphoproliferative disorders,4e15 association with massive sub-
retinal hemorrhage, also known as hemorrhagic retinal detach-
ment, appears to be a rare ocular manifestation of acute leukemia.
Herein, we describe a case of unilateral hemorrhagic retinal
detachment, concurrent with systemic manifestations and hema-
tological abnormalities as the initial presentation of acute pro-
myelocytic leukemia.ercial interests related to the
y work of this manuscript.
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This 14-year-old boy was brought to our hospital with a 2-week
history of progressive generalized bruises, decreased right eye
vision for 3 days, and a fever episode. Other associated symptoms
were weakness, nausea, cough, and blood-stained rhinorrhea.
There was no body weight loss, headache, chills, nor night sweat-
ing, and he had no history of any systemic disease, ocular trauma, or
surgery. Visual acuity was light sensation in the right eye and 20/30
in the left eye. Results of an ocular examination revealed bilateral
pale conjunctiva and decreased pupillary light response of right
eye. Ocular movements, cornea, anterior chamber, iris, and appla-
nation tonometry of both eyes were all normal. However, results of
a fundus examination showed macula-off retinal detachment with
vitreous hemorrhage in the right eye (Fig. 1). Axial B-scan ultraso-
nography showed echoes of a thin continuous line, indicating ret-
inal detachment, with echoes received from both anterior and
posterior sides of the detachment, presumed to be subretinal,
preretinal, and vitreous hemorrhage (Fig. 2A).
On physical examination, generalized ecchymosis and petechiae
were noted, but there was no neurologic sign, splenomegaly, nor
hepatomegaly. Results of laboratory investigations showed pan-
cytopenia with low platelet count (13,000/mL). Leukemic cells with
31% blast and 11% promyelocytes were also identiﬁed. Clotting
screen showed prolonged prothrombin time of 15.2 seconds, ele-
vated international normalized ratio of 1.4, and normal activated
partial thromboplastin time of 34.4 seconds. Elevated D-dimer
values (>10,000 ng/ml ﬁbrinogen equivalent units) andan. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Ocular fundus (oculus dexter) taken on the 2nd day after the ﬁrst emergency
department visit showed macula-off retinal detachment with vitreous hemorrhage.
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intravascular coagulation status. Serum biochemistry showed ele-
vated C-reactive protein (433.6 mg/dL) levels, whereas urate, renal
function, and liver function were within normal limits.Fig. 2. (A) Axial vertical view of ocular B-scan ultrasonography showing retinal
detachment with subretinal, preretinal, and vitreous hemorrhage. (B) Persistent ul-
trasonography ﬁndings on the 46th day after the ﬁrst emergency department visit.Based on the hematological abnormalities, the patient was
referred to hematological analysis. Platelet transfusion was given
immediately to correct the coagulopathy, and empirical antibiotics
treatment was administered. Because of the suspected acute pro-
myelocytic leukemia with disseminated intravascular coagulation,
chemotherapy with oral all-trans retinoic acid (ATRA) was pre-
scribed. Further analysis of the bone marrow aspirate showed
a hypercellular inﬁltrative marrow with markedly suppressed
normal cell elements. Approximately 80% of the total nucleated
cells were hypergranular myeloid precursors (leukemic promye-
locytes) and fewer (10%) were blasts. Some of the leukemic cells
had lobulated nucleus, and some had Auer rods, with Faggot cells
seen occasionally. The myeloperoxidase reaction was strongly
positive. The bone marrow specimen was sent for cytogenetic
analysis and translocation between chromosomes 15 and 17,
t(15;17) (q22;q21), was detected. A standard reverse transcriptase
polymerase chain reaction of the patient’s bone marrow sample
was performed and the L-form PML-RAR-a fusion gene was iden-
tiﬁed. The diagnosis of acute promyelocytic leukemia was then
conﬁrmed.
The patient was enrolled into chemotherapy with the Taiwan
Pediatric Oncology Group Acute Promyelocytic Leukemia 2001
protocol. He received three courses of induction chemotherapy
with oral ATRA, intrathecal methotrexate, and intravenous idar-
ubicin. Persistent severe thrombocytopenia deferred the oph-
thalmic surgery for hemorrhagic retinal detachment, until
completing the third course of induction chemotherapy and pla-
telet count improved to 158,000/mL without transfused platelet,
which was 10 weeks after the initial presentation. Preoperative
survey showed stationary subretinal and vitreous hemorrhage
(Fig. 2B), and visual acuity of the right eye remained light percep-
tion. Encircling scleral buckling with external drainage of clotted
subretinal hemorrhage without use of thrombolytic agent, three-
port vitrectomy, ﬂuidegas exchange, silicon oil tamponade, and
lensectomy were done. Severe proliferative vitreoretinopathy with
organized blood clot obscuring the retina was noted intra-
operatively. The operation was further complicated with unstop-
pable vitreous hemorrhage. The patient’s condition was followed
up 4 weeks postoperatively, revealing stationary right eye visual
acuity of light sensation. Molecular remission of acute promyelo-
cytic leukemia was ﬁnally achieved after receiving arsenic trioxide
chemotherapy. Further consolidation chemotherapy was then
arranged.
3. Discussion
Hemorrhagic retinal detachment could be seen in acute pro-
myelocytic leukemia as a complication of bleeding diathesis due to
thrombocytopenia and disseminated intravascular coagulation
status. The bleeding tendency may defer or/and complicate the
operation and may lead to visual morbidities.
Retinal detachment in leukemia is rare, and has been reported in
several cases of exudative retinal detachment with subretinal se-
rous ﬂuid accumulation.7 It may occur when the choroid layer is
inﬁltrated by the neoplastic cells, which decreases blood ﬂow
through the choriocapillaris, resulting in ischemia of the overlying
retinal pigment epithelium and disrupting intercellular tight
junctions.7,11 We herein described a case of acute promyelocytic
leukemia presenting with exudative retinal detachment with sub-
retinal hemorrhage. Acute promyelocytic leukemia is characterized
by its bleeding diathesis due to several processes including
thrombocytopenia and disseminated intravascular coagulation.16
The subretinal hemorrhage may arise from spontaneous extrava-
sation of red blood cells from choroidal circulation through dis-
rupted tight junction of retinal pigment epithelium.
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related macular degeneration, polypoidal choroidal vasculopathy,
presumed ocular histoplasmosis, high myopia, retinal arterial mac-
roaneurysm, and trauma.17 Published surgical series for the man-
agementof subretinal hemorrhage includedvitrectomyand internal
drainage with or without tissue plasminogen activator injection,
penetrating endodiathermy coagulation, and argon laser retinal
perforation.17 Several guidelines were proposed for the selection of
surgical candidates who will likely be beneﬁted from surgery,
including a duration of subretinal hemorrhage less than 30 days,
preferably less than 7 days.17 According to the guidelines of Ameri-
can Society of Hematology, platelet counts of at least 50,000/mL
should be maintained in surgical procedures. We performed encir-
cling scleral buckling, vitrectomy, and internal drainageof subretinal
hemorrhage in this patient when his platelet counts increased to
158,000/mL after completing a third course of induction chemo-
therapy without transfused platelets. However, the operation was
still complicated with intraoperative vitreous hemorrhage in addi-
tion to severe proliferative vitreoretinopathy and obscured retina by
organized blood clots. Defect in platelet function in patients with
leukemia or persistent deﬁciencies of clotting cascade due to coag-
ulating factors consumption following acute disseminated intra-
vascular coagulation may have contributed to the bleeding event.
Therefore, it is critical to perform a thorough survey of hemostasis
function preoperatively in leukemic patients undergoing surgery.
The prognosis of hemorrhagic retinal detachment is related to
several factors, including the duration of retinal detachment, the
presence of macular involvement, the thickness of the hemorrhagic
ﬂuid, and the etiologies of hemorrhagic retinal detachment.17
Another factor related to poor visual outcome is the retinal dam-
age secondary to subretinal hemorrhage, which has been shown in
animal model, and elucidated in three mechanisms: chemical
toxicity, mechanical traction on the photoreceptor outer segments,
and establishment of a diffusion barrier.17,18 The factors that con-
tributed to poor visual outcome in our case include the longer
duration of retinal detachment, which is 10 weeks after initial
presentation, macular involvement, and the presence of prolifera-
tive vitreoretinopathy.
Hemorrhagic retinal detachment could be a presentation in
acute promyelocytic leukemia. Prompt surgical evacuation of
subretinal hemorrhage and achieving reattachment of thephotoreceptor layer are important. Delayed interventions or
intraoperative hemorrhagic complications due to bleeding dia-
thesis may lead to visual morbidity.References
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